-
5
-
-
39749179066
-
-
For recent selected reviews, see
-
(a) For recent selected reviews, see:, Alonso F, Beletskaya I P., Yus M, Tetrahedron 2008 64 3047
-
(2008)
Tetrahedron
, vol.64
, pp. 3047
-
-
Alonso, F.1
Beletskaya, I.P.2
Yus, M.3
-
6
-
-
20544450502
-
-
2nd ed., Vol. 1, deMeijere A, Diederich F, Wiley-VCH Weinheim
-
(b) Miyaura N, In Metal-Catalyzed Cross-Coupling Reactions 2nd ed., Vol. 1, deMeijere A, Diederich F, Wiley-VCH Weinheim 2004 41
-
(2004)
In Metal-Catalyzed Cross-Coupling Reactions
, pp. 41
-
-
Miyaura, N.1
-
9
-
-
0034600318
-
-
For representative examples, see
-
(a) For representative examples, see:, Littke A F., Dai C, Fu G C., J. Am. Chem. Soc. 2000 122 4020
-
(2000)
J. Am. Chem. Soc.
, vol.122
, pp. 4020
-
-
Littke, A.F.1
Dai, C.2
Fu, G.C.3
-
11
-
-
3042654141
-
-
(c) Walker S D., Barder T E., Martinelli J R., Buchwald S L., Angew. Chem. Int. Ed. 2004 43 1871
-
(2004)
Angew. Chem. Int. Ed.
, vol.43
, pp. 1871
-
-
Walker, S.D.1
Barder, T.E.2
Martinelli, J.R.3
Buchwald, S.L.4
-
14
-
-
84961981994
-
-
(c) Organ M G., Chass G A., Fang D.-C, Hopkinson A C., Valente C, Synthesis 2008 2776
-
(2008)
Synthesis
, pp. 2776
-
-
Organ, M.G.1
Chass, G.A.2
Fang, D.-C.3
Hopkinson, A.C.4
Valente, C.5
-
16
-
-
0037090921
-
-
For representative examples, see
-
(a) For representative examples, see:, Gstöttmayr C W. K., Böhm V P. W., Herdtweck E, Grosche M, Herrmann [nl]W A., Angew. Chem. Int. Ed. 2002 41 1363
-
(2002)
Angew. Chem. Int. Ed.
, vol.41
, pp. 1363
-
-
Gstöttmayr, C.W.K.1
-
17
-
-
33746217438
-
-
(b) Herrmann W A., Öfele K, Schneider S K., Herdtweck E, Hoffmann S D., Angew. Chem. Int. Ed. 2006 45 3859
-
(2006)
Angew. Chem. Int. Ed.
, vol.45
, pp. 3859
-
-
Herrmann W, A.1
-
19
-
-
70349782152
-
-
(d) Organ M G., Çalimsiz S, Sayah M, Hoi K H., Lough A J., Angew. Chem. Int. Ed. 2009 48 2383
-
(2009)
Angew. Chem. Int. Ed.
, vol.48
, pp. 2383
-
-
Organ M, G.1
-
22
-
-
0037020372
-
-
(b) Schnyder A, Indolese A F., Studer M, Blaser H.-U, Angew. Chem. Int. Ed. 2002 41 3668
-
(2002)
Angew. Chem. Int. Ed.
, vol.41
, pp. 3668
-
-
Schnyder, A.1
Indolese, A.F.2
Studer, M.3
Blaser, H.-U.4
-
25
-
-
33746132446
-
-
Alacid E, Alonso D A., Botella L, Nájera C, Pacheco M C., Chem. Rec. 2006 6 117
-
(2006)
Chem. Rec.
, vol.6
, pp. 117
-
-
Alacid, E.1
Alonso, D.A.2
Botella, L.3
Nájera, C.4
Pacheco, M.C.5
-
26
-
-
0043094529
-
-
(a) Alonso D A., Nájera C, Pacheco M C., Org. Lett. 2000 2 1823
-
(2000)
Org. Lett.
, vol.2
, pp. 1823
-
-
Alonso D, A.1
-
27
-
-
0037047536
-
-
(b) Alonso D A., Nájera C, Pacheco M C., J. Org. Chem. 2002 67 5588
-
(2002)
J. Org. Chem.
, vol.67
, pp. 5588
-
-
Alonso D, A.1
-
33
-
-
0033546092
-
-
Goubet D, Meric P, Dormoy J.-R, Moreau P, J. Org. Chem. 1999 64 4516
-
(1999)
J. Org. Chem.
, vol.64
, pp. 4516
-
-
Goubet, D.1
Meric, P.2
Dormoy, J.-R.3
Moreau, P.4
-
34
-
-
0000077612
-
-
p -Biphenylacetic acid(felbinac) and 2-ethyl-4-biphenylacetic acid with dimethylaminoethanol-(namoxyrate) are anti-inflamatory and analgesic drugs, respectively: USP Dictionary of USAN and International Drugs names. p -Biphenylacetamides have been used as mesogenic arms in porphyrin thermotropic liquid crystals
-
p -Biphenylacetic acid(felbinac) and 2-ethyl-4-biphenylacetic acid with dimethylaminoethanol-(namoxyrate) are anti-inflamatory and analgesic drugs, respectively: USP Dictionary of USAN and International Drugs names. p -Biphenylacetamides have been used as mesogenic arms in porphyrin thermotropic liquid crystals:, Michaeli S, Hugerat M, Levanon H, Bernitz M, Natt A, Neumann R, J. Am. Chem. Soc. 1992 114 3612
-
(1992)
J. Am. Chem. Soc.
, vol.114
, pp. 3612
-
-
Michaeli, S.1
Hugerat, M.2
Levanon, H.3
Bernitz, M.4
Natt, A.5
Neumann, R.6
-
35
-
-
72049132018
-
-
note
-
At this point, the efficiency of the previously tested phosphane ligands with TBAOH as additive was tested again, showing in all cases lower activities. For example, P (t-Bu) 3 only led to a 31% isolated yield of 4a.
-
-
-
-
36
-
-
72049126912
-
-
note
-
Typical Procedure for the Suzuki Coupling under MW Irradiation Conditions (Table 2, Entry 3) A freshly stock soln of catalyst 1 (150 mg, 0.019 mmol) in DMF (2.5 mL) and [HP(t-Bu)3]BF4 (110 g, 0.0375 mmol) in DMF (2.5 mL) were previously prepared and used. A 10 mL MW vessel was charged with K2CO3 (1.5 mmol, 207 mg), TBAOH (0.15 mmol, 120 mg), PhB(OH)2 (1.88 mmol, 225 mg), catalyst 1 (250 mL of the stock soln, 0.0019 mmol, 15 mg, 0.5 mol% Pd), [HP(t-Bu)3]BF4 (250 mL of the stock soln, 0.00375 mmol, 11 mg), 4-chloroanisole (0.75 mmol, 92 mL), and DMF (1.5 mL). The vessel was sealed with a pressure lock, and the mixture was heated in air at 130 °C by a MW irradiation of 40 W for 20 min in a CEM Discover MW reactor. After allowing the reaction to cool down to r.t., the mixture was filtered through a pad of Celite and poured into an excess of H2O (5 mL) and extracted with Et2O (3 ×5 mL). The combined organic phases were washed with H2O (3 ×5 mL), dried (MgSO4), and evaporated. The obtained crude product was purified by recrystallization in MeOH-H2O (3:1), yielding 102 mg of pure 4-methoxybiphenyl (4a, 74%) as a white solid; mp 89-93 °C. 1H NMR (300 MHz, CDCl3): d = 7.57-7.51 (m, 4 H, ArH), 7.42 (t, J = 7.5 Hz, 2 H, ArH), 7.30 (t, J = 7.2 Hz, 1 H, ArH), 6.98 (d, J = 8.7 Hz, 2 H, ArH), 3.86 (s, 3 H, CHO). MS (EI, 70 eV): m/z (%) = 184 (100) [M+], 169 (49) [M+ - Me], 141 (49), 139 (13), 115 (35).
-
-
-
|